Survey on Cardiologists' Awareness of Inflammation and Biomarkers in Heart and Kidney Disease
Author Information
Author(s): Marx Nikolaus MD, Komuro Issei MD, PhD, Prasad Preethy PhD, Qian Juying MD, PhD, Saraiva José Francisco kerr MD, PhD, Zonoozi Amir Abbas mohseni MD, MSc, Shete Abhijit MD, Catapano Alberico L. PhD, MdHC
Primary Institution: University Hospital, RWTH Aachen University, Germany
Hypothesis
What are cardiologists' perceptions and awareness regarding systemic inflammation and high-sensitivity C-reactive protein as biomarkers in atherosclerotic cardiovascular disease and chronic kidney disease?
Conclusion
The study found that many cardiologists recognize the importance of systemic inflammation in cardiovascular risk but face challenges in its management due to limited treatment options.
Supporting Evidence
- 64% of cardiologists intend to test for systemic inflammation in managing patients with ASCVD.
- 73% agree that ongoing chronic inflammation contributes to the risk of recurrent cardiovascular events.
- 41% of cardiologists indicated that the results of testing for systemic inflammation could influence their treatment decisions.
Takeaway
Doctors who treat heart and kidney diseases know that inflammation is important, but they often don't have the right tools to help their patients.
Methodology
A cross-sectional, noninterventional, multinational online survey-based study conducted amongst cardiologists in 10 countries.
Potential Biases
Self-reported nature of the study may introduce bias.
Limitations
Potential participant recall bias and generalizability due to the use of an online panel.
Participant Demographics
Participants included interventional and general cardiologists from various regions, with a mean age of 47.2 years.
Statistical Information
P-Value
p<0.05
Confidence Interval
Not specified
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website